enVVeno Medical Corporation Financial Ratios — NVNOW Stock

Profitability	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-145.46	-389.79	-451.75	-218.07	-130.77	-48.44	-49.66	-52.09
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	-3.1	0.58	100	100	- -	- -	- -	- -
EBITDA Margin (%)	- -	-573.6	-1,412.91	-3,967.65	-21,412.24	- -	- -	- -	- -
Operating Margin (%)	- -	-592.84	-1,445.89	-4,039.17	-22,681.85	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	6,557.1	- -	- -	- -
Pretax Margin (%)	- -	-711.05	-1,845.83	-6,991.46	-24,406.74	- -	- -	- -	- -
Profit Margin (%)	- -	-431.03	-1,845.83	-6,991.46	-24,406.74	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	-474.65	-1,954.79	-8,765.77	-24,406.74	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.31	5.78	5.57	20.24	- -	6.23	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	2	1	3	- -	1	1	2	2	1
ST Debt	2	1	3	- -	- -	1	- -	- -	- -
LT Debt	- -	- -	- -	- -	1	- -	2	1	1
Total Debt/EBITDA	-1.57	-0.14	-0.44	- -	-0.13	-0.1	-0.12	-0.07	-0.06
Net Debt/EBITDA	-0.21	-0.13	-0.43	0.37	0.2	1.03	3.33	0.19	0.15
Total Debt/EBIT	-1.42	-0.14	-0.43	- -	-0.12	-0.1	-0.12	-0.07	-0.06
Net Debt/EBIT	-0.19	-0.12	-0.42	0.36	0.18	0.99	3.24	0.18	0.14
EBITDA to Interest Expense	-13.15	-77.87	-3.11	-1.08	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-13.18	-84.33	-3.11	-1.08	- -	- -	- -	- -	- -
EBIT to Interest Expense	-14.57	-80.48	-3.18	-1.1	- -	- -	- -	- -	- -
Interest Expense	- -	- -	2	7	- -	- -	- -	- -	- -
Common Equity/Total Assets	-846.7	-1,555.26	-1,603.68	-1,364.33	-1,636.13	-619.89	-141.86	-255.68	-267.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	57.37	3.57	3.15	3.62	2.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1.03	-0.39	-2.15	-1.34	-0.83
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	16.54	2.41	2.97	3.37	2.19
Total Debt/Equity (%)	-51.19	-15	-43.94	- -	86.53	12.41	3.69	4.43	3.03
Total Debt/Capital (%)	-8.13	-2.34	-9.44	- -	-1.55	-1.37	-2.51	-1.64	-1.09
Total Debt/Total Assets (%)	63.69	35.49	118.24	- -	24.94	8.36	3.48	4.12	2.88
Net Debt to Equity	-6.87	-13.66	-42.64	-134.58	-132.05	-127.11	-100.6	-11.76	-7.84
Net Debt/Capital (%)	-1.02	-2.12	-9.14	5.34	2.31	12.23	40.67	4.17	2.74
EBITDA	-1	-5	-6	-7	-7	-9	-16	-24	-25
EBITDA-CapEx	-1	-5	-6	-7	-7	-9	-17	-25	-25
Operating Income (Loss)	-1	-5	-6	-8	-7	-9	-17	-25	-25

Liquidity	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	0.34	0.03	0.01	1.8	0.7	2.93	34.64	25.52	33.85
Current Ratio	0.38	0.19	0.02	1.86	0.76	3	34.84	25.78	34.23
Quick Ratio	0.34	0.12	0.01	1.82	0.7	2.93	34.64	25.52	33.85
CFO/Avg Current Liab	- -	-1.02	-0.82	-1.31	-3.47	-3.03	-4.97	-10.04	-13
Common Equity/Total Assets	-846.7	-1,555.26	-1,603.68	-1,364.33	-1,636.13	-619.89	-141.86	-255.68	-267.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	57.37	3.57	3.15	3.62	2.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1.03	-0.39	-2.15	-1.34	-0.83
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	16.54	2.41	2.97	3.37	2.19
Total Debt/Equity (%)	-51.19	-15	-43.94	- -	86.53	12.41	3.69	4.43	3.03
Total Debt/Capital (%)	-8.13	-2.34	-9.44	- -	-1.55	-1.37	-2.51	-1.64	-1.09
Total Debt/Total Assets (%)	63.69	35.49	118.24	- -	24.94	8.36	3.48	4.12	2.88
CFO/Total Liabilities	-31.3	-56.93	-51.41	-417.33	-241.23	-223.18	-359.58	-532.71	-774.46
CFO/CapEx	-770.79	-9.15	-384.19	-511.66	-16.2	-42.58	-32.2	-135.82	-571.45
Altman's Z-Score	-21.15	-100.73	-71.51	-31.49	-29.86	-10.81	-1.84	-4.46	-4.33

Working Capital	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	66.89	14.39	5.55	1.95	- -	- -	- -	- -
Days Sales Outstanding	- -	5.46	25.37	65.74	187.05	- -	- -	- -	- -
Inventory Turnover	- -	17.83	9.23	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	20.47	39.53	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	1.55	0.33	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	234.96	1,106.49	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	-209.02	-1,041.58	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-15.02	-14.16	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	2	- -	- -	3	1	9	55	5	4
+ Preferred Equity and Hybrid Capital	- -	- -	5	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	1	3	- -	1	1	2	2	1
Enterprise Value	- -	1	8	-3	- -	-8	-53	-37	-45
Total Capital	-23	-27	-28	-49	-55	-64	-80	-105	-129
Total Debt/Capital (%)	-8.13	-2.34	-9.44	- -	-1.55	-1.37	-2.51	-1.64	-1.09
Total Debt / EV	7.45	1.1	0.34	- -	-1.9	-0.1	-0.04	-0.05	-0.03
EV/Sales	- -	0.73	18.27	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	1	8	-3	- -	-8	-53	-3	-2
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	1	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-1	-5	-6	-7	-7	-9	-16	-24	-25
TTM Operating Income	-1	-5	-6	-8	-7	-9	-17	-25	-25
TTM Cash Flow to Firm	-2	-3	-2	1	-6	-8	-12	-16	-19
TTM Free Cash Flow to Firm	-2	-3	-2	1	-6	-7	-11	-16	-19

Multiples	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	0.73	18.27	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	0.73	18.27	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	0.73	18.27	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	0.73	18.27	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.21	-0.13	-1.29	0.37	0.07	0.97	3.21	0.12	0.09
EV/EBITDA High	-0.21	-0.13	-1.29	0.37	0.07	0.97	3.21	0.12	0.09
EV/EBITDA Low	-0.21	-0.13	-1.29	0.37	0.07	0.97	3.21	0.12	0.09
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	-0.19	-0.12	-1.26	0.36	0.06	0.93	3.12	0.11	0.09
EV/EBIT High	-0.19	-0.12	-1.26	0.36	0.06	0.93	3.12	0.11	0.09
EV/EBIT Low	-0.19	-0.12	-1.26	0.36	0.06	0.93	3.12	0.11	0.09
Last Price	- -	- -	- -	0.44	0.1	0.32	0.29	0.06	0.01
High Price	- -	- -	- -	1.8	0.48	0.8	0.65	0.33	0.19
Low Price	- -	- -	- -	0.23	0.02	0.04	0.15	0.02	0.01
Enterprise Value	- -	1	8	-3	- -	-8	-53	-37	-45
Enterprise Value Average	- -	1	8	-3	- -	-8	-53	-3	-2
Enterprise Value High	- -	1	8	-3	- -	-8	-53	-3	-2
Enterprise Value Low	- -	1	8	-3	- -	-8	-53	-3	-2

Per Share Data Items	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	- -	- -	- -	- -	1	3	9	9	13
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -

enVVeno Medical Corporation

Profitability

Credit

Liquidity

Working Capital

Enterprise Value

Multiples

Per Share Data Items